• pharmacology home
  • personnel directory
  • faculty research
  • graduate training
    • program of study
    • curriculum
    • course descriptions
    • current students
    • alumni
    • student colloquia
  • postdoctoral training
    • current fellows
    • fellow openings
  • professional courses
    • medical pharmacology
    • dental pharmacology
  • research facilities
    • mass spectrometry
    • nuclear magnetic resonance spectrometry
    • proteomics
  • seminars


The Department of Pharmaceutical Sciences joins the Department of Pharmacology to present the following seminars, held Mondays at 4:00 PM in BSB-302 unless otherwise noted.


DATE
SPEAKER
TITLE
Thursday
January 12
Rita Young, Ph.D.
Associate Chief of Staff for Research
Va Medical Center
Professor of
Medicine and Otolaryngology
MUSC


Translating studies on cancer progression into therapeutic strategies.
(Associate Provost Candidate)
Tuesday
January 17
SEI 809

Kenneth Ramos, Ph.D.
Distinguished Professor
and Chairman
Biochemistry and Molecular Biology
Director, Center for Genetics
and Molecular Medicine
University of Louisville Health Sciences Center


Transcriptional control of LINE-1 retrotransposons in mammalian cells: implications in atherosclerosis and cancer.
(Associate Provost Candidate)
January 23 Steve Ladish, M.D.
Bosworth Chair for Cancer Biology
Director, Center for Cancer
and Immunology Research
Children's National Medical Center
Emory University


Tumor gangliosides, cell signaling, and tumor progression.
(Associate Provost Candidate)
Tuesday
January 24
1:00 PM
QF 302A
Bradford Gibson, Ph.D.
Professor and Director
Chemistry Core
Buck Institute for Age Research


Mitochondrial proteomics, aging and neurodegenerative disease.
Thursday
January 26
Michael Dockter, Ph.D.
Professor of Medicine
Associate Dean for Research
and Administration
University of Tennessee Health Sciences Center


Prenatal genetic diagnosis of fetal cells from maternal blood.
(Associate Provost Candidate)
January 30 Mark Kindy, Ph.D.
Director, Neuroscience Institute
Director, Phenomics Center
MUSC

A tale of two receptors: mechanisms and therapeutics in Alzheimer's disease.
(Associate Provost Candidate)
February 7
Tuesday
QF 302A
Mark G. Clemens, Ph.D.
Professor and Vice Chair
Department of Biology
UNC Charlotte


Endothelin / eNOS interactions in the liver following inflammatory stress.
February 13 David Basile, Ph.D.
Associate Professor
Cell and Integrative Physiology
Indiana Univeristy


Acute renal failure and the development of chronic disease: implications for altered vascular regulation.
February 20 Joseph Senn, Ph.D.
Assistant Professor
Pediatric Endocrinology
and Pharmacology
MUSC


Type 2 diabetes: cause and effect.
March 6
BSB 202
Adam VanWert
Graduate Student
Pharmaceutical Sciences

In vivo implications of organic anion transporter 3 knockout.
March 20 Dan Liebler, Ph.D.
Professor of Biochemistry
and Pharmacology
Director, Proteomics Laboratory
Vanderbilt University

Proteomic analysis of protein damage in chemical toxicity and oxidative stress.
March 27 Mark Hallman
Graduate Student
Pharmacology

In vitro transdifferentiation of renal proximal tubular cells following hydrogen peroxide-induced injury: a role for the EGF receptor.
April 3
Seminar Cancelled
Lakshmi Kotra, Ph.D.
Scientist, Toronto General Research Institute
Director, Molecular Design and Information Technology Center

Design of small molecule insulin mimetics: a rational approach.
Friday
April 7
12 noon
BSB 402
Xianquan Zhan, M.D., Ph.D.
Assistant Professor
The Charles B. Stout Neuroscience Mass Spectrometry Laboratory
University of Tennessee Health Science Center

Human pituitary tumor proteomics.
April 10 Gilbert Kinsey
Graduate Student
Pharmaceutical Sciences

Identification and characterization of iPLA2 gamma in renal cell mitochondria.
April 17 Gloriane Schnabolk
Graduate Student
Pharmaceutical Sciences

The novel murine organic anion transporter mOat6 (Slc22a20) mediates the transport of estrone sulfate.
April 24 No Seminar

 
May 1 Ryan Monfeli
Graduate Student
Pharmaceutical Sciences


Targeting IdeR as a potential therapy against Mycobacterium tuberculosis infections.
May 8 Scott Eblen, Ph.D.
Assistant Professor
Pharmacology and Experimental Therapeutics
MUSC

MAP kinase signaling in ovarian cancer.
May 15

Jennifer Isaacs, Ph.D.
Assistant Professor
Pharmacology and Experimental Therapeutics
MUSC


Inhibition of the Hsp90 chaperone as a potent anticancer therapeutic.
May 22

No seminar

 
June 5

No seminar

 
June 12

Giuseppe Gumina, Ph.D.
Assistant Professor
Pharmaceutical Sciences

Adenosine receptors as therapeutic targets.
June 26

Carola Neumann, M.D.
Assistant Professor
Pharmacology and Experimental Therapeutics
MUSC


Tumorigenesis and oxidative stress: a role for the antioxidant Prdx1 in tumor suppression.

Seminars of Old: fall 2005 | spring 2005 | fall 2004 | spring 2004 | fall 2003 | spring 2003 | fall 2002 | spring 2002 | fall 2001 | spring 2001 | fall 2000 | spring 2000 | fall 1999 | spring 1999 | fall 1998 | spring 1998 | fall 1997 | spring 1997


top of page

Google

Cell and Molecular Pharmacology 173 Ashley Avenue BSB 303 Box 250505 Charleston, SC  29425 Tel.: 843-792-2471 Fax: 843-792-2475

Copyright 2004. Comments or questions, please email webmaster.